The English hepatitis C registry shows only a modest effect from non-completion of directly-acting antivirals for hepatitis C: SVR rates over 80% in genotype 1, 2 or 3 HCV if more than one third of planned treatment is completed

Autor: Kate Drysdale, Yevedzo Ntuli, Jonathan Bestwick, Ceri Townley, Faizel Mahomed, Graham Foster
Rok vydání: 2020
Předmět:
Zdroj: Journal of Hepatology. 73:S348
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(20)31194-6
Databáze: OpenAIRE